Under pressure to deal, Biogen executives deflect urgency at JPM25

Under pressure to deal, Biogen executives deflect urgency at JPM25

Submitted by admin on January 15, 2025 - 11:33am
Source: 
BioSpace
News Tags: 
Biogen
JPMHC 2025
M&A
Chris Viehbacher
SAGE Therapeutics
Headline: 
Under pressure to deal, Biogen executives deflect urgency at JPM25
snippet: 

While investors and analysts push for a deal, Biogen CEO Chris Viehbacher and Head of Development Priya Singhal refuse to make one out of desperation.

Do Not Allow Advertisers to Use My Personal information